Futura Medical plc (LON:FUM – Get Free Report) fell 6.6% on Monday . The company traded as low as GBX 8.47 ($0.11) and last traded at GBX 8.97 ($0.12). 275,573 shares traded hands during trading, a decline of 58% from the average session volume of 648,906 shares. The stock had previously closed at GBX 9.60 ($0.13).
Futura Medical Price Performance
The company has a 50 day simple moving average of GBX 11.95 and a 200-day simple moving average of GBX 25.53. The stock has a market cap of £27.95 million, a P/E ratio of -7.40 and a beta of 1.25.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Articles
- Five stocks we like better than Futura Medical
- 10 Best Airline Stocks to Buy
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- Growth Stocks: What They Are, What They Are Not
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
